Pau Riera , Berta Martín-Cullell , Anna de Dios , Anna C. Virgili , Lucía Ramírez , David Páez
{"title":"通过EMMA Salud移动App监测结直肠癌患者化疗期间的不良反应和生活质量","authors":"Pau Riera , Berta Martín-Cullell , Anna de Dios , Anna C. Virgili , Lucía Ramírez , David Páez","doi":"10.1016/j.medcle.2025.106895","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and aim</h3><div>One third of patients with colorectal cancer (CRC) undergoing chemotherapy develop serious adverse effects. The aim was to monitor toxicities, evaluate quality of life and the usefulness of the EMMA Salud mobile App in these patients.</div></div><div><h3>Patients and methods</h3><div>Prospective single-center study including patients with CRC who started fluoropyrimidine-based chemotherapy treatment between 02/2022 and 02/2023. Through the mobile application, patients could record adverse effects, interact with healthcare professionals and answer quality of life (EORTC-CRC) and anxiety/depression (HADS) questionnaires.</div></div><div><h3>Results</h3><div>A total of 31 patients were included. Regarding the use of the App, 10 patients (32.2%) recorded variables of interest, 11 (35.5%) recorded toxicities and 10 (32.2%) sent direct messages to healthcare professionals. Many patients (48%) also used the telephone consultation from the nurse case manager. The response rate to HADS and EORTC-CRC was 30% at baseline and 10% at approximately 6 months.</div></div><div><h3>Conclusions</h3><div>Monitoring toxicities through a mobile application can improve communication in motivated patients who adhere to new technologies. However, the role of the nurse case manager continues to be a valuable resource.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"164 11","pages":"Article 106895"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Monitoring of adverse effects and quality of life during chemotherapy treatment through the EMMA Salud mobile App in patients with colorectal cancer\",\"authors\":\"Pau Riera , Berta Martín-Cullell , Anna de Dios , Anna C. Virgili , Lucía Ramírez , David Páez\",\"doi\":\"10.1016/j.medcle.2025.106895\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and aim</h3><div>One third of patients with colorectal cancer (CRC) undergoing chemotherapy develop serious adverse effects. The aim was to monitor toxicities, evaluate quality of life and the usefulness of the EMMA Salud mobile App in these patients.</div></div><div><h3>Patients and methods</h3><div>Prospective single-center study including patients with CRC who started fluoropyrimidine-based chemotherapy treatment between 02/2022 and 02/2023. Through the mobile application, patients could record adverse effects, interact with healthcare professionals and answer quality of life (EORTC-CRC) and anxiety/depression (HADS) questionnaires.</div></div><div><h3>Results</h3><div>A total of 31 patients were included. Regarding the use of the App, 10 patients (32.2%) recorded variables of interest, 11 (35.5%) recorded toxicities and 10 (32.2%) sent direct messages to healthcare professionals. Many patients (48%) also used the telephone consultation from the nurse case manager. The response rate to HADS and EORTC-CRC was 30% at baseline and 10% at approximately 6 months.</div></div><div><h3>Conclusions</h3><div>Monitoring toxicities through a mobile application can improve communication in motivated patients who adhere to new technologies. However, the role of the nurse case manager continues to be a valuable resource.</div></div>\",\"PeriodicalId\":74154,\"journal\":{\"name\":\"Medicina clinica (English ed.)\",\"volume\":\"164 11\",\"pages\":\"Article 106895\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina clinica (English ed.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2387020625002293\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2387020625002293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Monitoring of adverse effects and quality of life during chemotherapy treatment through the EMMA Salud mobile App in patients with colorectal cancer
Background and aim
One third of patients with colorectal cancer (CRC) undergoing chemotherapy develop serious adverse effects. The aim was to monitor toxicities, evaluate quality of life and the usefulness of the EMMA Salud mobile App in these patients.
Patients and methods
Prospective single-center study including patients with CRC who started fluoropyrimidine-based chemotherapy treatment between 02/2022 and 02/2023. Through the mobile application, patients could record adverse effects, interact with healthcare professionals and answer quality of life (EORTC-CRC) and anxiety/depression (HADS) questionnaires.
Results
A total of 31 patients were included. Regarding the use of the App, 10 patients (32.2%) recorded variables of interest, 11 (35.5%) recorded toxicities and 10 (32.2%) sent direct messages to healthcare professionals. Many patients (48%) also used the telephone consultation from the nurse case manager. The response rate to HADS and EORTC-CRC was 30% at baseline and 10% at approximately 6 months.
Conclusions
Monitoring toxicities through a mobile application can improve communication in motivated patients who adhere to new technologies. However, the role of the nurse case manager continues to be a valuable resource.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
